Finasteride for Hair Loss: How It Works, Dosage, and Timeline

Short answer: Finasteride is a once-daily pill that blocks the enzyme responsible for converting testosterone into DHT, the hormone that drives pattern hair loss. FDA-approved since 1992 at a 1mg dose for men, clinical trials show it takes at least 3 months to see results, with benefits typically lost within about a year of stopping. It's not approved for women, and there's an important FDA warning specific to compounded topical versions worth knowing about.

If you're considering finasteride or trying to understand what your prescriber has already recommended, here's what the actual FDA data shows — the mechanism, the real trial numbers, and what happens over time.

How Finasteride Actually Works

Finasteride blocks an enzyme called 5-alpha reductase — the same enzyme responsible for converting testosterone into DHT, the hormone that drives follicle miniaturization in pattern hair loss. By blocking that conversion, finasteride lowers DHT levels both in the bloodstream and directly in scalp tissue.

It works fast at the hormonal level: a single 1mg dose suppresses serum DHT by about 65% within 24 hours. The FDA's own labeling describes the effect in balding scalp specifically — men with pattern hair loss have measurably more DHT and more miniaturized follicles in affected areas compared to non-balding scalp, and finasteride is understood to interrupt that process in people who are genetically predisposed to it.

The two versions of the enzyme it targets

There are two forms of 5-alpha reductase in the body. Type I is mostly in the skin's sebaceous glands and accounts for roughly a third of circulating DHT. Type II is concentrated in the hair follicles, prostate, and related tissue, and accounts for roughly two-thirds of circulating DHT. Finasteride at the 1mg dose is highly selective for Type II — about 100 times more selective than for Type I in lab studies — which is the specific reason it's effective for hair loss at a relatively low dose.

FDA Approval and Dosing

Finasteride was first FDA-approved in 1992. The hair-loss-specific version, sold under the brand name Propecia, is approved at 1mg once daily, taken with or without food, in men only.

This is a different dose than the prostate medication with the same active ingredient. Finasteride is also sold as Proscar, at 5mg — five times the Propecia dose — for benign prostatic hyperplasia (enlarged prostate), not hair loss. These are genuinely different products with different approved uses, even though the active ingredient is identical.

One data point worth knowing if you're prescribed finasteride and later get routine bloodwork: at the 1mg hair-loss dose, PSA (prostate-specific antigen, a standard prostate screening marker) drops modestly — from an average of 0.7 to 0.5 ng/mL over 12 months in trial data. At the higher 5mg dose used for BPH, PSA drops by roughly 50%. If you're on finasteride and get a PSA test for an unrelated reason, this is worth mentioning to whoever orders it, since it can affect how the result should be interpreted.

Finasteride is not approved for use in women, and there's a real reason. FDA labeling explicitly states it's not indicated for women and lists pregnancy as a contraindication. Because finasteride blocks a hormone pathway involved in normal male fetal development, it may cause abnormalities in a male fetus if a pregnant woman is exposed to it — including through simply handling crushed or broken tablets, which is why intact coated tablets are considered safe to handle normally, but crushed ones are not. A dedicated FDA-reviewed study in 137 postmenopausal women also found no meaningful benefit from finasteride in that population — it didn't improve hair count or any other measured outcome.

A specific warning worth knowing: compounded topical finasteride

There is no FDA-approved topical finasteride product. The FDA has separately issued an alert about compounded topical versions specifically, after receiving reports of side effects — including erectile dysfunction, anxiety, depression, and decreased libido — consistent with what's seen with the oral version, plus an added risk of accidental transfer to others (including pregnant women) through skin contact.

What the Clinical Trials Actually Found

The FDA approval was based on three year-long, placebo-controlled trials involving 1,879 men, ages 18–41, with mild-to-moderate (not complete) hair loss.

Hair count results, measured in a defined area of the scalp:

• At 12 months: 107 more hairs on average with finasteride vs. placebo
• At 2 years: 138 more hairs — this was the peak benefit
• At 5 years: 277 more hairs vs. placebo — though this growing gap was driven mostly by continued decline in the untreated group, not continued gains in the treated group

Investigator-assessed improvement:

• At 12 months: 65% of finasteride-treated men were rated as having increased growth, vs. 37% on placebo
• At 5 years: 77% vs. just 15%

Does it regrow hair, or just stop loss?

Both, to a degree — treated men maintained hair counts above their own starting point for up to 5 years in the trial data, while untreated men declined below their starting point over the same period. That said, most of finasteride's own gains happened in the first two years; after that, the widening gap between groups reflects the placebo group continuing to decline more than the treated group continuing to improve.

Does it keep working long-term?

An independent 10-year follow-up study of 118 men found efficacy wasn't reduced over time — about a fifth of participants actually saw better results after 5 years than before. Response varied by age and starting severity: men over 30 and those with more advanced hair loss tended to see more improvement, while nearly 43% of men in their 20s showed no improvement even after a full decade. Reported side effects in this long-term cohort were low, at about 6% of patients.

Timeline: What to Actually Expect

Clinical guidance is consistent on this point: daily use for at least 3 months is necessary before any benefit shows up, and the original trials found statistically significant improvement by that point compared to placebo.

Benefits require continued use to maintain — the FDA label is direct about this, stating that continued use is recommended to sustain results, and that stopping treatment reverses the effect within about 12 months. In rare cases, some sexual side effects have been reported to persist even after stopping, though semen quality has also been reported to normalize or improve after discontinuation in some cases.

Frequently Asked Questions